Scientists from the pharmaceutical company AstraZeneca, with the support of neutrons at the Heinz Maier-Leibnitz Zentrum (MLZ), have now discovered how the subcutaneous administration of mRNA can be improved. For this, the small angle scattering diffractometer KWS-2 at MLZ was used. The goal is for…
[read more]